These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 7952798

  • 1. Protein binding of itraconazole and fluconazole in patients with chronic renal failure.
    Arredondo G, Martinez-Jorda R, Calvo R, Aguirre C, Suarez E.
    Int J Clin Pharmacol Ther; 1994 Jul; 32(7):361-4. PubMed ID: 7952798
    [Abstract] [Full Text] [Related]

  • 2. Protein binding of itraconazole and fluconazole in patients with cancer.
    Arredondo G, Calvo R, Marcos F, Martínez-Jordá R, Suarez E.
    Int J Clin Pharmacol Ther; 1995 Aug; 33(8):449-52. PubMed ID: 8556224
    [Abstract] [Full Text] [Related]

  • 3. Binding of alfentanil to human alpha 1-acid glycoprotein, albumin and serum.
    Belpaire FM, Bogaert MG.
    Int J Clin Pharmacol Ther Toxicol; 1991 Mar; 29(3):96-102. PubMed ID: 2071261
    [Abstract] [Full Text] [Related]

  • 4. Characteristics of serum protein binding of felodipine.
    Valle M, Esteban M, Rodríguez-Sasiaín JM, Calvo R, Aguirre C.
    Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):73-88. PubMed ID: 8948016
    [Abstract] [Full Text] [Related]

  • 5. Unchanged protein binding of penbutolol in renal insufficiency: a possible role of carbamylation.
    Aguirre C, Calvo R, Rodriguez-Sasiain JM.
    Int J Clin Pharmacol Ther Toxicol; 1993 Jan; 31(1):31-4. PubMed ID: 8444514
    [Abstract] [Full Text] [Related]

  • 6. Interindividual variability in the concentrations of albumin and alpha-1-acid glycoprotein in patients with renal or liver disease, newborns and healthy subjects: implications for binding of drugs.
    Viani A, Rizzo G, Carrai M, Pacifici GM.
    Int J Clin Pharmacol Ther Toxicol; 1992 Apr; 30(4):128-33. PubMed ID: 1572757
    [Abstract] [Full Text] [Related]

  • 7. Serum binding of ketoconazole in health and disease.
    Martínez-Jordá R, Rodriguez-Sasiain JM, Suárez E, Calvo R.
    Int J Clin Pharmacol Res; 1990 Apr; 10(5):271-6. PubMed ID: 2079384
    [Abstract] [Full Text] [Related]

  • 8. Ex vivo protein binding of clindamycin in sera with normal and elevated alpha 1-acid glycoprotein concentrations.
    Kays MB, White RL, Gatti G, Gambertoglio JG.
    Pharmacotherapy; 1992 Apr; 12(1):50-5. PubMed ID: 1549539
    [Abstract] [Full Text] [Related]

  • 9. Binding of bupivacaine to human serum proteins, isolated albumin and isolated alpha-1-acid glycoprotein. Differences between the two enantiomers are partly due to cooperativity.
    Mazoit JX, Cao LS, Samii K.
    J Pharmacol Exp Ther; 1996 Jan; 276(1):109-15. PubMed ID: 8558418
    [Abstract] [Full Text] [Related]

  • 10. Factors affecting serum protein binding of cocaine in humans.
    Parker RB, Williams CL, Laizure SC, Lima JJ.
    J Pharmacol Exp Ther; 1995 Nov; 275(2):605-10. PubMed ID: 7473145
    [Abstract] [Full Text] [Related]

  • 11. Age- and gender-related differences in carbohydrate concentrations of alpha1-acid glycoprotein variants and the effects of glycoforms on their drug-binding capacities.
    Kishino S, Nomura A, Itoh S, Nakagawa T, Takekuma Y, Sugawara M, Furukawa H, Todo S, Miyazaki K.
    Eur J Clin Pharmacol; 2002 Dec; 58(9):621-8. PubMed ID: 12483455
    [Abstract] [Full Text] [Related]

  • 12. Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugs.
    Morse DS, Abernethy DR, Greenblatt DJ.
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):535-9. PubMed ID: 3934087
    [Abstract] [Full Text] [Related]

  • 13. Serum protein binding of itraconazole and fluconazole in patients with diabetes mellitus.
    Arredondo G, Suárez E, Calvo R, Vazquez JA, García-Sanchez J, Martinez-Jordá R.
    J Antimicrob Chemother; 1999 Feb; 43(2):305-7. PubMed ID: 11252341
    [Abstract] [Full Text] [Related]

  • 14. Interaction between human serum albumin and alpha 1-acid glycoprotein in the binding of lidocaine to purified protein fractions and sera.
    Krauss E, Polnaszek CF, Scheeler DA, Halsall HB, Eckfeldt JH, Holtzman JL.
    J Pharmacol Exp Ther; 1986 Dec; 239(3):754-9. PubMed ID: 3795040
    [Abstract] [Full Text] [Related]

  • 15. Altered protein binding of quinidine in patients with atrial fibrillation and flutter.
    McCollam PL, Crouch MA, Watson JE.
    Pharmacotherapy; 1997 Dec; 17(4):753-9. PubMed ID: 9250553
    [Abstract] [Full Text] [Related]

  • 16. Protein binding of indomethacin, methotrexate and morphine in patients with cancer.
    Raveendran R, Heybroek WM, Caulfield M, Abrams SM, Wrigley PF, Slevin M, Turner P.
    Int J Clin Pharmacol Res; 1992 Dec; 12(3):117-22. PubMed ID: 1473877
    [Abstract] [Full Text] [Related]

  • 17. Enantioselective gallopamil protein binding.
    Gross AS, Eser C, Mikus G, Eichelbaum M.
    Chirality; 1993 Dec; 5(6):414-8. PubMed ID: 8398599
    [Abstract] [Full Text] [Related]

  • 18. Serum protein binding of lerisetron, a novel specific 5HT3 antagonist, in patients with cancer.
    Calvo R, Jiménez RM, Trocóniz IF, Suárez E, Gonzalo A, Lucero ML, Raczka E, Orjales A.
    Cancer Chemother Pharmacol; 1998 Dec; 42(5):418-22. PubMed ID: 9771958
    [Abstract] [Full Text] [Related]

  • 19. Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition.
    Nishio T, Takamura N, Nishii R, Tokunaga J, Yoshimoto M, Kawai K.
    Nephrol Dial Transplant; 2008 Jul; 23(7):2304-10. PubMed ID: 18390890
    [Abstract] [Full Text] [Related]

  • 20. Alpha-1-acid glycoprotein concentrations and protein binding of propranolol in Sprague-Dawley and Dark Agouti rat strains treated by phenobarbital.
    Chauvelot-Moachon L, Delers F, Poüs C, Engler R, Tallet F, Giroud JP.
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1103-8. PubMed ID: 3252025
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.